Phase 1 Cholestatic Liver Disease Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease

CirrhosisCholestatic Liver DiseaseHepatic Impairment

Zydus Therapeutics Inc.30 enrolled1 locationNCT05045482

Recruiting

Phase 1

Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease

Cholestatic Liver Disease

Zydus Therapeutics Inc.6 enrolled1 locationNCT06825559